Virtu Financial’s Elevation Oncology ELEV Stock Holding History

Virtu Financial’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,318	Closed	-$18K	–	1625
2025 Q2	$18K	Buy	+50,318	New	+$16.8K	﹤0.01%	1263
2025 Q1	–	Sell	-63,974	Closed	-$36K	–	1533
2024 Q4	$36K	Buy	+63,974	New	+$37.8K	﹤0.01%	1202
2023 Q2	–	Sell	-27,286	Closed	-$52K	–	1652
2023 Q1	$52K	Buy	+27,286	New	+$35.2K	0.01%	1085
2022 Q3	–	Sell	-21,798	Closed	-$31K	–	1855
2022 Q2	$31K	Buy	+21,798	New	+$54.7K	﹤0.01%	1244

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Virtu Financial's ELEV Position: Q3 2025 in Review

Virtu Financial sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 50,318 shares — an estimated $18K sold.

Virtu Financial first reported a position in ELEV in Q2 2022 and held it in 4 quarters. The position peaked at $52K in Q1 2023. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Virtu Financial reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Virtu Financial sold 50,318 Elevation Oncology shares in Q3 2025, an estimated $18K.
Virtu Financial first reported a position in Elevation Oncology in Q2 2022 and held it in 4 quarters.
Virtu Financial's Elevation Oncology position peaked at $52K in Q1 2023.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.